| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454111 | Lung Cancer | 2018 | 7 Pages |
Abstract
Although liquid biopsy is a relevant tool to diagnose T790M presence in NSCLC patients resistant to EGFR-TKI, in case of a low ratio T790M/activating mutation, tissue biopsy should be considered to exclude the presence of SCLC transformation and/or other concomitant resistance mechanisms.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
R. Minari, P. Bordi, M. Del Re, F. Facchinetti, F. Mazzoni, F. Barbieri, A. Camerini, C.E. Comin, L. Gnetti, C. Azzoni, R. Nizzoli, B. Bortesi, E. Rofi, P. Petreni, N. Campanini, G. Rossi, R. Danesi, M. Tiseo,